Bacolod City is among the identified sites in the country where Janssen Pharmaceutical Companies of Johnson & Johnson will conduct Phase 3 clinical trials for its coronavirus disease 2019 (Covid-19) vaccine.
City Administrator Em Ang said members of the Emergency Operations Center (EOC) were briefed by Dr. Adonis Guancia, the principal administrator of the Johnson & Johnson vaccine clinical trial in the city, about the development during a meeting held on Wednesday at the Bacolod Government Center.
“They are currently recruiting volunteers for the pivotal Phase 3 trials of the Janssen Covid-19 vaccine,” Ang, who is also the EOC executive director and deputy for administration and operations, said in a statement posted on Facebook.
She also posted that “(t)he randomized, placebo-controlled clinical trial is designed to evaluate the safety and efficacy of the vaccine in at least 500 adults, 40 years old and older, including significant representation from those who have comorbidities”.
“The trials mark the first for a Covid-19 vaccine in the Philippines and would allow the Philippines to contribute to worldwide knowledge on the development of a Covid-19 vaccine. The trials will also help scientists and medical experts confirm the effects of the vaccine on Filipinos,” the post added.
Janssen is among the two Covid-19 vaccine developers that have secured approval from the Department of Health’s Ethics Review Board last December.In a Facebook post on Jan. 23, Guancia said the clinical trial will start on Feb. 1. SOVEREIGNPH